We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Results for 'strategic alliances ADC'

Content Type: All
Sorted by: Relevance

Keywords
 
Content Type
 
Sort by
 
 

Showing 1 to 10 results of 4839

News

Fujifilm Diosynth Biotechnologies Announces Strategic Alliance with Piramal Healthcare

Strategic alliance for the production of antibody drug conjugates.
News

Servier and Galapagos Initiate Strategic Alliance in Osteoarthritis

The multi-year strategic alliance aims to discover and develop novel small molecules for osteoarthritis.
News

MorphoSys Secures Full-Term of Strategic Alliance

Novartis has committed to a ten-year term of the strategic alliance originally signed in December 2007.
News

ChemWare Enters Strategic Alliance with Healthpac Computer Systems to Enhance Billing Processes For Laboratories

ChemWare has entered into a strategic alliance with Healthpac Computer Systems
Article

PerkinElmer and Tibco Software Announce Strategic Alliance for Spotfire Data Visualization and Discovery

Strategic alliance leverages strengths of both organizations
News

Galapagos Achieves Milestones in Two Strategic Alliances

Alliance with Janssen Pharmaceutica in rheumatoid arthritis triggers a milestone payment of €1.5 million.
News

Bioject Establishes Strategic Alliance with MPI Research

Strategic collaboration expands each organization’s resources, capabilities and potential opportunities.
News

Tripos Names New VP of Business Development and Strategic Alliances, Discovery Research

Dr. Tom Mander has been appointed as VP of business development and strategic alliances, Discovery Research.
News

Seattle Genetics and Oxford BioTherapeutics to Collaborate on ADCs for Cancer

Companies to combine proprietary technologies to generate novel ADC product candidates.
News

Menarini and OBT Sign Major Strategic Collaboration

Strategic alliance for the clinical development and manufacture of a portfolio of novel antibody-based cancer drugs.
Advertisement